Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Merit Medical (MMSI)
:MMSI
Holding MMSI?
Track your performance easily
MMSI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$70.70 - $108.08
Previous CloseN/A
Volume49.13K
Average Volume (3M)487.25K
Market Cap
$5.95B
Enterprise Value$6.18B
Total Cash (Recent Filing)$19.17M
Total Debt (Recent Filing)$314.37M
Price to Earnings (P/E)50.4
Beta0.48
Next Earnings
Feb 25, 2025EPS Estimate
0.82Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.04
Shares Outstanding58,279,408
10 Day Avg. Volume557,010
30 Day Avg. Volume487,249
Standard Deviation0.08
R-Squared0.28
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.49
Price to Cash Flow (P/CF)31.40
P/FCF Ratio39.80
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue4.66
Enterprise Value/Gross Profit10.58
Enterprise Value/Ebitda29.09
Forecast
1Y Price Target
$113.78Price Target Upside10.57% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Merit Medical Systems News
PremiumCompany Announcements
Merit Medical Systems Reveals Strong 2024 Revenue Growth
PremiumCompany Announcements
Merit Medical Systems Announces Leadership Change Amid Investigation
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMerit Medical preannounced 2024 revenue above consensus expectations, indicating strong performance.
Product Launch And Market PotentialWrapsody's commercialization in the U.S. is expected to have a substantial impact, potentially generating significant revenue with attractive margins.
Regulatory ApprovalMerit's Wrapsody endoprosthesis has received premarket approval from the U.S. FDA, indicating a positive regulatory milestone for the company.
Bears Say
CEO Succession PlanMr. Wright’s resignation is expected to reignite questions about Merit’s CEO succession plan.
Leadership StabilityMMSI President and potential CEO successor resigns following undisclosed allegations regarding his conduct.
Strategic ExecutionMr. Wright’s departure is seen as a meaningful loss to the company as he has been an instrumental part of Merit’s strategy and execution.
---
Ownership Overview
2.42% Insiders
39.31% Mutual Funds
0.35% Other Institutional Investors
31.65% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MMSI FAQ
What was Merit Medical’s price range in the past 12 months?
Merit Medical lowest stock price was $70.70 and its highest was $108.08 in the past 12 months.
What is Merit Medical’s market cap?
Merit Medical’s market cap is $5.95B.
When is Merit Medical’s upcoming earnings report date?
Merit Medical’s upcoming earnings report date is Feb 25, 2025 which is in 36 days.
How were Merit Medical’s earnings last quarter?
Merit Medical released its earnings results on Oct 30, 2024. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.798 by $0.062.
Is Merit Medical overvalued?
According to Wall Street analysts Merit Medical’s price is currently Undervalued.
Does Merit Medical pay dividends?
Merit Medical does not currently pay dividends.
What is Merit Medical’s EPS estimate?
Merit Medical’s EPS estimate is 0.82.
How many shares outstanding does Merit Medical have?
Merit Medical has 58,279,408 shares outstanding.
What happened to Merit Medical’s price movement after its last earnings report?
Merit Medical reported an EPS of $0.86 in its last earnings report, beating expectations of $0.798. Following the earnings report the stock price went up 3.962%.
Which hedge fund is a major shareholder of Merit Medical?
Currently, no hedge funds are holding shares in MMSI
---
Merit Medical Systems Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$113.78 (10.57% Upside)
$113.78 (10.57% Upside)
Blogger Sentiment
Bullish
MMSI Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 234.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▲ 16.0%
Last 30 Days ▲ 16.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.99%
12-Months-Change
Fundamentals
Return on Equity
9.40%
Trailing 12-Months
Asset Growth
31.49%
Trailing 12-Months
Company Description
Merit Medical
Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates advanced non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger and William Padilla in July 1987 and is headquartered in South Jordan, UT.
---
MMSI Company Deck
---
MMSI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Merit Medical delivered strong revenue and profitability growth, alongside significant free cash flow and positive clinical trial results for WRAPSODY. However, challenges remain in the OEM segment due to supply chain issues and a decline in China sales. The strategic acquisition of Cook Medical's portfolio is expected to enhance future growth.Read More>---
MMSI Stock 12 Month Forecast
Average Price Target
$113.78
▲(10.57% Upside)
Technical Analysis
Best Analysts Covering MMSI
1 Year
1 Year Success Rate
15/19 ratings generated profit
1 Year Average Return
+15.11%
assigned a buy rating 3 months ago
Copying Jason Bednar's trades and holding each position for 1 Year would result in 78.95% of your transactions generating a profit, with an average return of +15.11% per trade.
---